Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Long-Term Debt Repayments (2016 - 2018)

Wave Life Sciences (WVE) has disclosed Long-Term Debt Repayments for 4 consecutive years, with $16000.0 as the latest value for Q1 2018.

  • For the quarter ending Q1 2018, Long-Term Debt Repayments changed 0.0% year-over-year to $16000.0, compared with a TTM value of $16000.0 through Dec 2018, down 74.19%, and an annual FY2018 reading of $16000.0, down 74.19% over the prior year.
  • Long-Term Debt Repayments was $16000.0 for Q1 2018 at Wave Life Sciences, up from $15000.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $16000.0 in Q1 2016 and bottomed at $14000.0 in Q4 2015.
  • Average Long-Term Debt Repayments over 4 years is $15363.6, with a median of $15000.0 recorded in 2015.
  • The sharpest move saw Long-Term Debt Repayments rose 7.14% in 2016, then changed 0.0% in 2017.
  • Year by year, Long-Term Debt Repayments stood at $14000.0 in 2015, then grew by 7.14% to $15000.0 in 2016, then changed by 0.0% to $15000.0 in 2017, then grew by 6.67% to $16000.0 in 2018.
  • Business Quant data shows Long-Term Debt Repayments for WVE at $16000.0 in Q1 2018, $15000.0 in Q4 2017, and $16000.0 in Q3 2017.